What We’re Reading: Boosting Vaccine Rates; Purdue Pharma Immunity; Decriminalizing Psychedelics
President Joe Biden announces a new initiative to get more adults vaccinated against COVID-19; Purdue Pharma may be immune from future opioid-related lawsuits; the California senate approves a bill decriminalizing psychedelic drugs.
Initiative Encourages COVID-19 Vaccinations
President Joe Biden
Purdue Pharma May Be Immune From Future Opioid Lawsuits
This week, a bankruptcy plan for Purdue Pharma, the maker of Oxycontin (oxycodone), cleared a major hurdle when a federal judge in White Plains, New York, moved forward a controversial deal despite objections, NPR
California Senate Votes to Decriminalize Psychedelics
The California senate approved legislation to decriminalize the possession or sharing of psychedelic drugs, according to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025